Cargando…

A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial

BACKGROUND: Polypharmacy is prevalent among hospitalized older adults, particularly those being discharged to a post-care care facility (PAC). The aim of this randomized controlled trial is to determine if a patient-centered deprescribing intervention initiated in the hospital and continued in the P...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasilevskis, Eduard E., Shah, Avantika S., Hollingsworth, Emily K., Shotwell, Matthew S., Mixon, Amanda S., Bell, Susan P., Kripalani, Sunil, Schnelle, John F., Simmons, Sandra F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416929/
https://www.ncbi.nlm.nih.gov/pubmed/30871561
http://dx.doi.org/10.1186/s12913-019-3995-3
_version_ 1783403457890222080
author Vasilevskis, Eduard E.
Shah, Avantika S.
Hollingsworth, Emily K.
Shotwell, Matthew S.
Mixon, Amanda S.
Bell, Susan P.
Kripalani, Sunil
Schnelle, John F.
Simmons, Sandra F.
author_facet Vasilevskis, Eduard E.
Shah, Avantika S.
Hollingsworth, Emily K.
Shotwell, Matthew S.
Mixon, Amanda S.
Bell, Susan P.
Kripalani, Sunil
Schnelle, John F.
Simmons, Sandra F.
author_sort Vasilevskis, Eduard E.
collection PubMed
description BACKGROUND: Polypharmacy is prevalent among hospitalized older adults, particularly those being discharged to a post-care care facility (PAC). The aim of this randomized controlled trial is to determine if a patient-centered deprescribing intervention initiated in the hospital and continued in the PAC setting reduces the total number of medications among older patients. METHODS: The Shed-MEDS study is a 5-year, randomized controlled clinical intervention trial comparing a patient-centered describing intervention with usual care among older (≥50 years) hospitalized patients discharged to PAC, either a skilled nursing facility (SNF) or an inpatient rehabilitation facility (IPR). Patient measurements occur at hospital enrollment, hospital discharge, within 7 days of PAC discharge, and at 60 and 90 days following PAC discharge. Patients are randomized in a permuted block fashion, with block sizes of two to four. The overall effectiveness of the intervention will be evaluated using total medication count as the primary outcome measure. We estimate that 576 patients will enroll in the study. Following attrition due to death or loss to follow-up, 420 patients will contribute measurements at 90 days, which provides 90% power to detect a 30% versus 25% reduction in total medications with an alpha error of 0.05. Secondary outcomes include the number of medications associated with geriatric syndromes, drug burden index, medication adherence, the prevalence and severity of geriatric syndromes and functional health status. DISCUSSION: The Shed-MEDS trial aims to test the hypothesis that a patient-centered deprescribing intervention initiated in the hospital and continuing through the PAC stay will reduce the total number of medications 90 days following PAC discharge and result in improvements in geriatric syndromes and functional health status. The results of this trial will quantify the health outcomes associated with reducing medications for hospitalized older adults with polypharmacy who are discharged to post-acute care facilities. TRIAL REGISTRATION: This trial was prospectively registered at clinicaltrials.gov (NCT02979353). The trial was first registered on 12/1/2016, with an update on 09/28/17 and 10/12/2018. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-019-3995-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6416929
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64169292019-03-25 A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial Vasilevskis, Eduard E. Shah, Avantika S. Hollingsworth, Emily K. Shotwell, Matthew S. Mixon, Amanda S. Bell, Susan P. Kripalani, Sunil Schnelle, John F. Simmons, Sandra F. BMC Health Serv Res Study Protocol BACKGROUND: Polypharmacy is prevalent among hospitalized older adults, particularly those being discharged to a post-care care facility (PAC). The aim of this randomized controlled trial is to determine if a patient-centered deprescribing intervention initiated in the hospital and continued in the PAC setting reduces the total number of medications among older patients. METHODS: The Shed-MEDS study is a 5-year, randomized controlled clinical intervention trial comparing a patient-centered describing intervention with usual care among older (≥50 years) hospitalized patients discharged to PAC, either a skilled nursing facility (SNF) or an inpatient rehabilitation facility (IPR). Patient measurements occur at hospital enrollment, hospital discharge, within 7 days of PAC discharge, and at 60 and 90 days following PAC discharge. Patients are randomized in a permuted block fashion, with block sizes of two to four. The overall effectiveness of the intervention will be evaluated using total medication count as the primary outcome measure. We estimate that 576 patients will enroll in the study. Following attrition due to death or loss to follow-up, 420 patients will contribute measurements at 90 days, which provides 90% power to detect a 30% versus 25% reduction in total medications with an alpha error of 0.05. Secondary outcomes include the number of medications associated with geriatric syndromes, drug burden index, medication adherence, the prevalence and severity of geriatric syndromes and functional health status. DISCUSSION: The Shed-MEDS trial aims to test the hypothesis that a patient-centered deprescribing intervention initiated in the hospital and continuing through the PAC stay will reduce the total number of medications 90 days following PAC discharge and result in improvements in geriatric syndromes and functional health status. The results of this trial will quantify the health outcomes associated with reducing medications for hospitalized older adults with polypharmacy who are discharged to post-acute care facilities. TRIAL REGISTRATION: This trial was prospectively registered at clinicaltrials.gov (NCT02979353). The trial was first registered on 12/1/2016, with an update on 09/28/17 and 10/12/2018. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-019-3995-3) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-14 /pmc/articles/PMC6416929/ /pubmed/30871561 http://dx.doi.org/10.1186/s12913-019-3995-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Vasilevskis, Eduard E.
Shah, Avantika S.
Hollingsworth, Emily K.
Shotwell, Matthew S.
Mixon, Amanda S.
Bell, Susan P.
Kripalani, Sunil
Schnelle, John F.
Simmons, Sandra F.
A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial
title A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial
title_full A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial
title_fullStr A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial
title_full_unstemmed A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial
title_short A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial
title_sort patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the shed-meds randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416929/
https://www.ncbi.nlm.nih.gov/pubmed/30871561
http://dx.doi.org/10.1186/s12913-019-3995-3
work_keys_str_mv AT vasilevskiseduarde apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT shahavantikas apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT hollingsworthemilyk apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT shotwellmatthews apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT mixonamandas apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT bellsusanp apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT kripalanisunil apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT schnellejohnf apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT simmonssandraf apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT vasilevskiseduarde patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT shahavantikas patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT hollingsworthemilyk patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT shotwellmatthews patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT mixonamandas patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT bellsusanp patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT kripalanisunil patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT schnellejohnf patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT simmonssandraf patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial
AT patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial